A Covid-19 vaccination that is effective against several variants could be available by the end of 2022, according to Pfizer’s CEO. Chairman Albert Bourla said the company was also working on a vaccine that would provide good protection for a whole year, requiring individuals to return annually for boosters, similar to how influenza vaccinations are […]